Figure 3 | British Journal of Cancer

Figure 3

From: Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients

Figure 3

The prevalence of mutations in common cancer genes from the Cancer 2015 cohorts compared with other institutional-based series. Reported prevalence of mutations in colorectal adenocarinoma, breast-invasive carcinoma, lung adenocarcinoma and head and neck squamous cell carcinoma as reported by public mutational catalogues (COSMIC and TCGA) compared with the Cancer 2015 cohort.

Back to article page